Utility of automated data transfer for cancer clinical trials and considerations for implementation

M. Pfeffer , M. Deneris , A. Shelley , P. Salcuni , I. Altomare
{"title":"Utility of automated data transfer for cancer clinical trials and considerations for implementation","authors":"M. Pfeffer ,&nbsp;M. Deneris ,&nbsp;A. Shelley ,&nbsp;P. Salcuni ,&nbsp;I. Altomare","doi":"10.1016/j.esmorw.2025.100112","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The burden of data collection on site staff for cancer clinical trials is steadily increasing, and inefficiencies in data entry into electronic data capture (EDC) systems lead to poor data quality and delays in reporting. Software that facilitates automated transfer of mapped structured data from the electronic health record (EHR) to EDC can help to address these challenges.</div></div><div><h3>Materials and methods</h3><div>We examined the impact of multi-site usage of an embedded point and click EHR-to-EDC tool on study data capture across multiple phase I cancer clinical trials by conducting a retrospective analysis of volume of and time for data transfer across protocols.</div></div><div><h3>Results</h3><div>During a 15-month observation period, the EHR-to-EDC tool was used to transfer 11 342 individual data points (89% laboratory values, 8% vitals and 3% concomitant medications) representing 955 unique case report form (CRF) submissions. Use was consistent across protocols. The average time for a user to launch, complete and submit a CRF was 37 s (range 15-59 s).</div></div><div><h3>Conclusions</h3><div>This study demonstrates efficiencies in clinical trial conduct provided by EHR-to-EDC technology and supports growing adoption among sites and sponsors, while highlighting how variability in data standards and interoperability across EHR systems pose practical challenges to widespread implementation.</div></div>","PeriodicalId":100491,"journal":{"name":"ESMO Real World Data and Digital Oncology","volume":"7 ","pages":"Article 100112"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESMO Real World Data and Digital Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949820125000013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

The burden of data collection on site staff for cancer clinical trials is steadily increasing, and inefficiencies in data entry into electronic data capture (EDC) systems lead to poor data quality and delays in reporting. Software that facilitates automated transfer of mapped structured data from the electronic health record (EHR) to EDC can help to address these challenges.

Materials and methods

We examined the impact of multi-site usage of an embedded point and click EHR-to-EDC tool on study data capture across multiple phase I cancer clinical trials by conducting a retrospective analysis of volume of and time for data transfer across protocols.

Results

During a 15-month observation period, the EHR-to-EDC tool was used to transfer 11 342 individual data points (89% laboratory values, 8% vitals and 3% concomitant medications) representing 955 unique case report form (CRF) submissions. Use was consistent across protocols. The average time for a user to launch, complete and submit a CRF was 37 s (range 15-59 s).

Conclusions

This study demonstrates efficiencies in clinical trial conduct provided by EHR-to-EDC technology and supports growing adoption among sites and sponsors, while highlighting how variability in data standards and interoperability across EHR systems pose practical challenges to widespread implementation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study Core variables for real-world clinicogenomic data collection in precision oncology Cancer in public figures, 2010-2020 Definitions, measurement, and reporting of progression-free survival in randomized clinical trials and observational studies of patients with advanced non-small-cell lung cancer treated with immunotherapy: a scoping review Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1